Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eucalyptus oil is a distilled essential oil derived from the leaves of Eucalyptus trees, primarily Eucalyptus globulus. It is widely used for its medicinal properties including as a cough suppressant, decongestant for nasal congestion and asthma, topical analgesic for arthritis and muscular pain, and as an antimicrobial agent. The primary active component in many preparations is 1,8-cineole (eucalyptol), which can comprise up to 80% or more of the oil. Eucalyptus oil exhibits anti-inflammatory effects by modulating immune responses and inhibiting cytokine production in vitro; it also demonstrates antibacterial activity against certain bacterial species. The exact mechanism of action remains incompletely understood but may involve inhibition of prostaglandin and cytokine formation by monocytes[1][2]. Eucalyptol is also commonly used in mouthwashes and cold remedies. Eucalyptus oil must be diluted before use; ingestion at full strength can be toxic[4]. It interacts with several medications metabolized by cytochrome P450 enzymes (CYP1A2/2C19/2C9/3A4) and may lower blood sugar levels when combined with antidiabetic drugs[5][8]. Used both topically and via inhalation; not recommended for oral ingestion due to toxicity risk.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on eucalyptus oil.